Daily

Here’s a few of the health startups that stood out at HealthBeat

As HealthBeat drew to a close, ten digital health startups took to the stage in an attempt to convince healthcare techies (healthies? hechies?) that they were all the next big thing disrupting  the toughest problems with in an industry fraught technological hurdles. All have great ideas and intentions, undoubtedly, but a few stood out, in […]

By Dan Verel on October 29, 2014

As HealthBeat drew to a close, ten digital health startups took to the stage in an attempt to convince healthcare techies (healthies? hechies?) that they were all the next big thing disrupting  the toughest problems with in an industry fraught technological hurdles.

All have great ideas and intentions, undoubtedly, but a few stood out, in part because they already have customers, clients or partnerships. That never hurts. Others simply stood for the idea and execution. And judging from reactions on social media, the  following seemed to resonate a bit more.

Doctor on Demand, which it looking to tap into telemedicine for employers. Recently, it signed on with Castlight Health to take its video visits directly to companies. The San Francisco startup demonstrated its video visit through a mobile app, during which a physician counseled the presenter regarding a rash. If employers embrace telemedicine, as some reports have suggested, then the functionality of this will be vital.

Syapse’s precision medicine data platform seemed to resonate with the crowd. It’s aim is to incorporate genomic and clinical data into one electronic patient record that a physicians can use at the point of care. The data is presented in a functional fashion on a time line showing medications that a patient takes during certain periods with health outcomes shown above.

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

By PurpleLab

QPID Health, which has told me that some news is coming soon, displayed its optimization platform for EHRs. Its software can grab clinical data related to the effectiveness of certain therapies while providing a break out for specialties like diabetes or oncology.

Infermedical stood out for its use of artificial intelligence that seeks to help doctors with clinical diagnosis. Using a laptop or tablet, the patient is able to enter their information into the software, which then physician can then access and add their own assessment and treatment plan.

And Zephyr Health presented its analytics program that pulls data from a number of disparate sets and organizes it into a more cohesive manner for providers.

Other startups presenting were:
Big Health
Bright.md
Hygeia Health
Omicia
RxMatch